Effect of Prostaglandin D 2 on mRNA Expression of Three Isoforms of Hyaluronic Acid Synthase in Nasal Polyp Fibroblasts

Abstract

Background

Hyaluronan is one of the major extracellular matrixes in chronic rhinosinusitis (CRS) associated with tissue remodeling. Prostaglandin D₂ (PGD₂) is also associated with the pathogenesis of CRS. However, little is known about whether PGD₂ regulates hyaluronan production by human airway fibroblasts.

Objective

We sought to determine the effect of PGD₂ on the mRNA expression of three isoforms of membrane-bound hyaluronic acid synthase (HAS1, HAS2 and HAS3) in fibroblasts, the major source of hyaluronan production, derived from CRS patients.

Methods

Nasal polyp-derived fibroblasts (NPDF) and uncinate tissue-derived fibroblasts (UTDF) were established from CRS patients with nasal polyps and those without, respectively. These fibroblasts were stimulated with PGD₂ or PGD₂ receptor (DP/CRTH2)-selective agonists in the presence or absence of receptor-selective antagonists. mRNA levels for HAS1, HAS2 and HAS3 were determined by real-time quantitative PCR.

Results

PGD₂ (1 µM) significantly enhanced HAS1 but not HAS2 or HAS3 mRNA expression by NPDF. Enhanced HAS1 mRNA expression was also obtained by stimulation with a DP receptor-selective agonist, but not with a CRTH2 receptor-selective agonist. In addition, PGD₂-induced HAS1 mRNA expression was significantly inhibited by pre-treatment with DP receptor-selective antagonists. Similar induction of PGD₂-induced HAS1 mRNA expression was seen in UTDF.

Conclusion

PGD₂ selectively stimulates HAS1 mRNA expression in local fibroblasts in CRS via DP, but not CRTH2, receptors.

Keywords

chronic rhinosinusitis DP fibroblast hyaluronic acid synthase PGD2

Get full access to this article

View all access options for this article.

References

Kato

Immunophathology of chronic rhinosinusitis. Allergol Int. 2015; 64(2):121–130.

Stevens WW, Lee RJ, Schleimer RP, Cohen NA. Chronic rhinosinusitis pathogenesis. J Allergy Clin Immunol. 2015; 136(6):1442–1453.

Cho

Kim

Gevaert

Chronic rhinosinusitis without nasal polyps. J Allergy Clin Immunol Pract. 2016; 4(4):575–582.

Kostamo K, Toskala E, Tervahartila T, Sorsa T. Role of matrix metalloproteinases in chronic rhinosinusitis. Curr Opin Allergy Clin Immunol. 2008; 8(1):21–27.

Yang YC, Zhang N, Van Crombruggen K, Hu GH, Hong SL, Bachert C. Transforming growth factor-beta 1 in inflammatory airway diseases: a key for understanding inflammation and remodeling. Allergy. 2012; 67(10):1193–1202.

Okano

Fujiwara

Yamamoto

, et al. Role of prostaglandin D₂ and E₂ terminal synthases in chronic rhinosinusitis. Clin Exp Allergy. 2006; 36(8):1028–1038.

Kanai

Okano

Fujiwara

, et al. Effect of prostaglandin D₂ on VEGF release by nasal polyp fibroblasts. Allergol Int. 2016; 65(4):414–419.

Takabayashi

Kato

Peters

, et al. Increased expression of factor XIII-A in patients with chronic rhinosinusitis with nasal polyps. J Allergy Clin Immunol. 2013; 132(3):584–594.

Hatziri A, Vynios DH, Panogeorgou T, et al. Presence of hyaloronidase isoforms in nasal polyps. Eur Rev Med Pharmacol Sci. 2013; 17:247–252.

10.

Panogeorgou

Tserbini

Filou

, et al. Hyaluronan syntheses and hyaloronidases in nasal polyps. Eur Arch Otorhinolaryngol. 2016; 273(7):1801–1808.

11.

Cassandro

Chiarella

Cavaliere

, et al. Hyaluronan in the treatment of chronic rhinosinusitis with nasal polyposis. Indian J Otolaryngol Head Neck Surg. 2015; 67(3):299–307.

12.

Pawlowska-Goral K, Gierek T, Majzel K, Wardas P, Wardas M. Glycosaminoglycans in nasal polyps. Acta Otolaryngol. 2005; 125(2):177–179.

13.

Jiang

Liang

Noble

PW.

Hyaluronan as an immune regulator in human diseases. Physiol Rev. 2011; 91:211–264.

14.

Stern

Asari

Sugahara

Hyaluronan fragments: an information-rich system. Eur J Cell Biol. 2006; 85(8):699–715.

15.

Bollyky

Lord

Masewicz

, et al. Cutting edge: high molecular weight hyaluronan promotes the suppressive effects of CD4⁺CD25⁺ regulatory T cells. J Immunol. 2007; 179(2):744–747.

16.

Gebe

Yadava

Ruppert

, et al. Modified high-molecular-weight hyaluronan promotes allergen-specific immune tolerance. Am J Respir Cell Mol Biol. 2017; 56(1):109–120.

17.

Hamann KJ, Dowling TL, Neeley SP, Grant JA, Leff AR. Hyaluronic acid enhances cell proliferation during eosinopoiesis through the CD44 surface antigen. J Immunol. 1995; 154:4073–4080.

18.

Ohkawara Y, Tamura G, Iwasaki T, Tanaka A, Kikuchi T, Shirato K. Activation and transforming growth factor-beta production in eosinophils by hyaluronan. Am J Respir Cell Mol Biol. 2000; 23(4):444–451.

19.

Yamamoto

Okano

Fujiwara

, et al. Expression and characterization of PGD₂ receptors in chronic rhinosinusitis: modulation of DP and CRTH2 by PGD₂. Int Arch Allergy Immunol. 2009; 148(2):127–136.

20.

Oguma

Asano

Ishizaka

Role of prostaglandin D₂ and its receptors in the pathophysiology of asthma. Allergol Int. 2008; 57(4):307–312.

21.

Guo N, Baglole C, O’Loughlin CW, Feldon SE, Phipps RP. Mast cell-derived prostaglandin D₂ controls hyaluronan synthesis in human orbital fibroblasts via DP1 activation: implications for thyroid eye disease. J Biol Chem. 2010; 285(21):15794–15804.

22.

Fokkens

Lund

Mullo

, et al. European position paper on rhinosinusitis and nasal polyps. Rhinol Suppl. 2012; 23:1–298.

23.

Wilkinson TS, Potter-Perigo S, Tsoi C, Altman LC, Wight TN. Pro- and anti-inflammatory factors cooperate to control hyaluronan synthesis in lung fibroblasts. Am J Respir Cell Mol Biol. 2004; 31(1):92–99.

24.

Siiskonen H, Oikari S, Pasonen-Seppanen S, Rilla K. Hyalunonan synthase 1: a mysterious enzyme with unexpected functions. Front Immunol. 2015; 6:43.

25.

Brinck

Heldin

Expression of recombinant hyaluronan synthase (HAS) isoforms in CHO cells reduces cell migration and cell surface CD44. Exp Cell Res. 1999; 252(2):342–351.

26.

Ferguson

Kulkarni

Lehmann

, et al. Electrophilic peroxisome proliferator-activated receptor-gamma ligands have potent antifibrotic effects in human lung fibroblasts. Am J Respir Cell Mol Biol. 2009; 41(6):722–730.

27.

Yoshimura T, Yoshikawa M, Otori N, Haruna S, Moriyama H. Correlation between the prostaglandin D₂/E₂ ratio in nasal polyps and the recalcitrant pathophysiology of chronic rhinosinusitis associated with bronchial asthma. Allergol Int. 2008; 57(4):429–436.